- TLDR Biotech
- Archive
- Page 14
The Latest Biotech & Pharma Updates
Biotech & Pharma Updates | July 29 - 30, 2024
BioNTech & Regeneron's mRNA cancer combo reports positive Ph2 data, Merck & Co. takes earnings hit after surprise Gardasil sales slowdown in China, Roche kicks off injectable GLP-1 Ph2 trial, Pfizer looks back on track with recent earnings report, and GLP-1s may help combat smoking
Biotech & Pharma Updates | July 28 - 29, 2024
GSK and Flagship sign 10 drug development partnership, Boehringer Ingelheim pays up to $1.3B for Nerio Therapeutics, Merck gets positive Keytruda opinion from CHMP, Spear Bio spears $45M Series A, Cognition Therapeutics handed Ph2 Alzheimer's L, and Pfizer lays off 200+ employees across two sites
Biotech & Pharma Updates | July 25 - 28, 2024
BMS' strong earnings bump stock up 10%, Dexcom stock drops 40% after lowering 2024 sales forecast, multiple big pharmas land EU adcomm thumbs up, while Biogen, Eisai's Leqembi for Alzheimer's gets a thumbs down from the same committee, and Confo Therapeutics raises $65M for small molecule & antibody drug discovery
Biotech & Pharma Updates | July 24 - 25, 2024
Pfizer lands EU approval for their hemophilia B gene therapy, a bunch of big pharmas report earnings, Chevron Doctrine might be resurrected, Ipsen buys pediatric cancer ex-US rights from Day One Biopharmaceuticals, while Roche, AbbVie, and Sanofi all clear out some of their clinical assets
Biotech & Pharma Updates | July 23 - 24, 2024
Pfizer's hemophilia A gene therapy posts positive Ph3, Novo Nordisk's Wegovy gets MHRA approval for a new indication, Gilead unveils full dataset for 100% efficacy HIV prevention shot, highway to funding with Autobahn's $100M Series C, FDA expresses doubt about AstraZeneca's lung cancer med prior to adcomm, and Novo Nordisk has their fourth fire of the year
Biotech & Pharma Updates | July 19 - 21, 2024
Eli Lilly ok'd to sell Zepbound in China, a $520M animal health antibody acquisition, Siga lands $113M US smallpox antiviral supply contract, GRO Biosciences GROws with $60.3M Series B, Artiva bests their own expectations with $167M IPO, and ICER isn't happy at all with Pfizer's ATTR heart disease med price
Biotech & Pharma Updates | July 16 - 17, 2024
Roche's obesity pill posts positive Ph1, J&J earnings stay positive despite looming IRA, NGM nabs $122M raise after going private, Sanofi doubles Hyderabad workforce, Actuate's $50M upcoming IPO, FDA launches rare disease innovation hub, and Roche's Genentech bails on Relay Therapeutics partnership
Biotech & Pharma Updates | July 15 - 16, 2024
Cardurion raises $260M for cardiac small molecules, CordenPharma invests nearly a billion in GLP-1 capacity expansion, Sionna gets hands on abandoned AbbVie CF asset, Vertex and Orum partner on new Casgevy conditioning regiment, ICER doesn't like Verona's COPD treatment price
